Aspirin Provides No Benefit for Breast Cancer Recurrence, Survival
FRIDAY, May 3, 2024 -- Among participants with high-risk nonmetastatic breast cancer, daily aspirin use did not improve the risk for breast cancer recurrence or survival in early follow-up, according to a study published online April 29 in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 3, 2024 Category: Pharmaceuticals Source Type: news
Indoor climbing wall users may be breathing in toxic rubber dust linked to CANCER
The air in popular indoor rock climbing wall facilities is laden with potentially toxic rubber particles, some of which have been linked to cancer, new research suggests. (Source: the Mail online | Health)
Source: the Mail online | Health - May 3, 2024 Category: Consumer Health News Source Type: news
Drug Trials Snapshots: AUGTYRO
AUGTYRO is a drug used to treat adult patients with advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 3, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
IVF babies at greater risk of leukaemia, study finds - but experts claim older, 'less fit' parents could be to blame
French scientists discovered children conceived using frozen embryos had a 61 per cent greater chance of developing the blood cancer later in life. (Source: the Mail online | Health)
Source: the Mail online | Health - May 3, 2024 Category: Consumer Health News Source Type: news
Active Surveillance Lawsuits; More Eligibility for Studies; Biosimilars Make News
(MedPage Today) -- A study of malpractice lawsuits related to active surveillance for prostate cancer found "no evidence of successful malpractice litigation," leading the authors to conclude that active surveillance "represents a sound management... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 3, 2024 Category: Hematology Source Type: news
Overall Cancer Risk Not Increased for Children Born After Assisted Reproduction
FRIDAY, May 3, 2024 -- The overall risk for cancer is not increased for children born after medically assisted reproduction (MAR), according to a study published online May 2 in JAMA Network Open.Paula Rios, M.D., Ph.D., from the French National... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 3, 2024 Category: Pharmaceuticals Source Type: news
2020 Cancer Screening Rates Low at Federally Qualified Health Centers
FRIDAY, May 3, 2024 -- In 2020, there were major gaps in screening clients at federally qualified health centers (FQHCs) for various types of cancer when compared with the general population, according to a study published online April 29... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 3, 2024 Category: Pharmaceuticals Source Type: news
Digital Health Sector Slowed Down in 2023 Digital Health Sector Slowed Down in 2023
Although the average amount raised in European funding rounds decreased, the number of investors increased by nearly one quarter.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 3, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Plant-Based Diet May Aid Prostate Cancer Outcomes
FRIDAY, May 3, 2024 -- Consuming a primarily plant-based diet may be associated with better cancer-specific health outcomes among men with prostate cancer, according to a study published online May 1 in JAMA Network Open.Vivian N. Liu, from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 3, 2024 Category: Pharmaceuticals Source Type: news
Extending Interval Between Colonoscopies Feasible After Negative Result
FRIDAY, May 3, 2024 -- For individuals without a family history of colorectal cancer (CRC), increasing the interval between colonoscopies for those with a first colonoscopy with negative findings seems safe and can avoid unnecessary colonoscopies,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 3, 2024 Category: Pharmaceuticals Source Type: news
ADAO Webinar Recap: Firefighting and Legacy Asbestos
The Asbestos Disease Awareness Organization held a webinar this week highlighting the need for a total asbestos ban and the dangers of legacy asbestos, which is found in older buildings, schools and homes. ADAO Co-Founder Linda Reinstein led the webinar and introduced the panelists of experts.
Dr. Raja Flores, Dr. Dan Whu and Greg Russell with the International Association of Fire Fighters, Brent Kynoch from the Environmental Information Association, ADAO counsel Bob Sussman and Reinstein discussed the need to combat misinformation and raise awareness about the presence of asbestos. They noted many people may not ...
Source: Asbestos and Mesothelioma News - May 3, 2024 Category: Environmental Health Authors: Travis Rodgers Tags: Asbestos (general) Asbestos Exposure Clinical Trials/Research/Emerging Treatments Doctors/Specialists Mesothelioma Support/Support Groups/Organizations Source Type: news
In the early steps of cancer formation, timing matters
Using powerful, high-resolution microscopy, a Yale-led team of scientists has revealed the very first cancer-triggering physical changes in mouse skin cells. (Source: Yale Science and Health News)
Source: Yale Science and Health News - May 3, 2024 Category: Universities & Medical Training Source Type: news
MicroRNAs Predict Pancreatic Cancer Risk Years in Advance MicroRNAs Predict Pancreatic Cancer Risk Years in Advance
Expression levels of several microRNAs in plasma samples can help predict the onset of pancreatic cancer up to 5 years prior to clinical diagnosis.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 3, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Clinical Summary Source Type: news
Drug targeting RNA modifications shows promise for treating neuroblastoma
Neuroblastoma is a common pediatric cancer that originates in developing nerve cells outside the brain. While increasingly intensive treatments have improved the survival of patients with high-risk neuroblastoma, currently more than 40% of patients do not survive.
New research from the University of Chicago shows the potential for a promising new approach to treating neuroblastoma by targeting RNA modifications associated with the disease. (Source: World Pharma News)
Source: World Pharma News - May 3, 2024 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
What's Driving Higher Breast Cancer Deaths in Black Women? What's Driving Higher Breast Cancer Deaths in Black Women?
Despite improvements in breast cancer screening and treatment, Black women experience higher death rates and more aggressive forms of the disease than White women.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 3, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
